Viewing StudyNCT00078234



Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00078234
Status: COMPLETED
Last Update Posted: 2011-11-06
First Post: 2004-02-20

Brief Title: Genasense Oblimersen Sodium Fludarabine and Rituximab in Subjects With Chronic Lymphocytic Leukemia
Sponsor: Genta Incorporated
Organization: Genta Incorporated

Conditions & Keywords Data

Conditions:
Name
Chronic Lymphocytic Leukemia
Keywords:
Name View
CLL View
Leukemia View
Chronic View
Cancer View
Adult View
Lymphocytic View
Genasense View
G3139 View
Genta View
Bcl-2 View
Antisense View
Oligonucleotide View
oblimersen View